01

Hugel Names Taiwan a Key Growth Market for Letybo Aesthetic Push

Hugel is targeting Taiwan as a priority growth market for its botulinum toxin Letybo and its wider aesthetic portfolio, aiming to expand adoption across Asia's high-volume clinic base.